News
EXCLUSIVE: Neuralink dragged into humane testing lawsuit – Timeline of Events
Neuralink has been dragged into a lawsuit by the Physicians Committee for Responsible Medicine against the University of California at Davis. The lawsuit, which is amended from its initial filing date of May 2021, seeks to have UC Davis release images and video of inhumanely-treated test subjects, including monkeys, who died after participating in some trials of Neuralink-sponsored research for the development of neural interface implant devices. We have put together an exclusive timeline of events based on interviews and an examination of over 700 pages of documents that UC Davis was required to turn over to the PCRM.
The Physicians Committee for Responsible Medicine (PCRM) is a nonprofit organization with more than 17,000 doctor members. It filed a formal complaint with the United States Department of Agriculture today, claiming UC Davis and Neuralink staff violated the federal Animal Welfare Act related to experiments performed on 23 monkeys. Neuralink paid more than $1.4 million to UC Davis to carry out the experiments.
The PCRM said in a press release that Neuralink and the University “failed to provide dying monkeys with adequate veterinary care, used an unapproved substance known as “Bioglue” that killed monkeys by destroying portions of their brains, and failed to provide for the psychological well-being of monkeys assigned to the experiment.”
In an exclusive interview with Teslarati earlier today, Jeremy Beckham, MPA, MPH, PCRM’s Research Advocacy Coordinator, said that the lawsuit really intends to open up “basic facts about what Neuralink testing did to the animals.” Beckham said monkeys had their brains mutilated in the experiments. Veterinary records, which were shared with Teslarati by the PCRM, show that UC Davis and Neuralink staff performed invasive and deadly experiments on monkeys to assess the effectiveness of the Neuralink device. The letter sent from the PCRM to the USDA earlier today gives several graphic descriptions of how the test animals were treated.
RELATED:
Neuralink details humane animal treatment during Link v0.9 testing
One animal, known as “Animal 6,” was a 6-year-old macaque monkey who was killed on January 16, 2019. The letter states that, on October 10, 2018, implanted electrodes “were placed using an investigational robot,” then, “attached to skull using titanium implant screws.” The location of the screws began to become infected, according to the letter. By January 14th, “Animal 6” had started to pick at the infected area. Staff euthanized the monkey two days later.
Timeline of Events
PCRM has been working to clarify the situation since September 2020, but a more descriptive timeline of events would clarify how Neuralink, UC Davis, and the PCRM have all combined into this issue.
- May 2017 – The University of California at Davis and Neuralink sign and agree to Non-Disclosure Agreements regarding testing.
- September 2017 – UC Davis and Neuralink officially begin their collaboration to carry out primate experiments at UC Davis facilities. The goal is to develop a brain-machine interface.
- July 2018 – “Animal 4,” an 11-year-old macaque monkey is killed in the Neuralink/UC Davis experiments, according to the complaint. The monkey was “on anti-depressants and had chronic diarrhea and poor appetite.” Additionally, the monkey was observed as “lethargic” and “depressed,” and hunched and passed bloody diarrhea. The monkey eventually died in a deadly procedure on July 20th.
- Also in July 2018 – “Animal 12,” approximately 7-years-old, undergoes a craniotomy and electrode insertion procedure. Records show the animal had “severe clinical adverse effects following the implantation, had poor stool quality, was not eating, and had an eye infection.” Records abruptly ended on July 30th.
- September 2018 – “Animal 21,” a 7-year-old female macaque undergoes an “electrode insertion survivability” procedure using “investigational robotics.” The animal was observed with adverse side effects the following day, including vomiting, gasping, retching, and had little interaction with their environment and observers. The animal was euthanized and had signs of “Bioglue,” an unapproved adhesive, covering the brain.
- December 2018 – “Animal 15,” a 7-year-old female macaque undergoes a craniotomy and recording device implantation. Following the surgery, the area became infected and bloody. The animal was euthanized on March 21, 2019. The performed necropsy shows “remnant electrode threads.”
- January 2019 – “Animal 6,” a 6-year-old macaque monkey is killed as a part of the “experimental design.” Electrodes were secured by screws drilled into the monkey’s skull, and lab staff were forced to “frequently clean” the eroding skin near the monkey’s implant site.
- March 2019 – “Animal 11” is killed at approximately 11-years-old during a terminal procedure. The monkey had an implant placed on the head or brain on December 3rd, 2018, and began experiencing symptoms like a weakened appetite and missing fingers and toes, possibly caused by self-mutilation.
- January 2020 – “Animal 5,” another macaque monkey is killed “inadvertently” by an anticonvulsant. He showed signs of significant weight loss and alopecia.
- July 2020 – Neuralink’s Elon Musk announces that the company will hold an event on August 28th, 2020, to display the progress of the V0.9 device. “Will show neurons firing in real-time on August 28th. The matrix in the matrix,” Musk said in a Tweet.
- Also in July 2020 – Neuralink receives a ‘breakthrough device’ designation from the FDA in July, and the company is working with the agency to make the technology as safe as possible.
- August 2020 – Neuralink unveils the v0.9 device, displaying healthy and functioning pigs. Musk delivers a presentation on the new device, showing the simplified product Neuralink has developed. “It’s like a FitBit in your skull with tiny wires,” Musk half-joked. “I could have it right now and you wouldn’t even know. Maybe I do!” The device is said to be installed without general anesthesia. There will be no bleeding, and no noticeable damage after the device is implanted.
- September 2020 – The PCRM files a California Public Records request, wishing for information regarding UC Davis trials of the Neuralink device. The request is eventually denied in accordance with California State Code 6255(a), which says that the Agency “shall justify withholding any record by demonstrating that the record in question is exempt under express provisions of this chapter or that on the facts of the particular case the public interest served by not disclosing the record clearly outweighs the public interest served by disclosure of the record.”
- October 2020 – “Animal 10,” an 8-year-old macaque monkey, is shipped to Neuralink’s facility in Fremont. The monkey has significant hair loss, had lesions from “unspecified traumas,” and was exhibiting self-mutilating behavior.
- November 2020 – Neuralink severs ties with UC Davis on November 11. Neuralink then moves seven of the remaining monkeys to its facility in Fremont, California. Beckham said that records show 15 of the 23 monkeys used in the research died or were euthanized at UC Davis. The final monkey’s situation is unclear, but it is possible the animal was reassigned to a different project at UC Davis, Beckham said.
- April 2021 – Neuralink releases a YouTube video of “Pager the Monkey” allegedly playing video games with a wireless neural interface. The video features a nine-year-old Macaque named Pager playing “MindPong” while utilizing a Neuralink device.
- May 2021 – PCRM sues the University of California Davis under the California Public Records Act (CPRA) for not releasing records in September 2020. Before the suit reaches a judicial decision, Counsel for the University of California agrees to release 700 pages of information.
- October 2021 – University of California’s General Counsel turns over files including animal testing records and veterinarian reports to PCRM. More than 700 pages of records are turned over.
- February 2022 – PCRM files a separate complaint with the U.S. Department of Agriculture that alleges the information the organization has already received reveals evidence of violations of Federal Animal Welfare laws.
Moving Forward
Beckham maintains that the main point of the newest filing is to have UC Davis turn over photographs and videos that reveal the inhumane treatment of the animals due to the experiments. There are monkeys convulsing, vomiting, and dying in these labs,” Beckham said. “People want to step in line for the first human trials, and they should see this before they commit to that,” he told Teslarati. Neuralink was set for human trials this year, Musk said last year.
Beckham said that these complaints can take a while to work through the legal system. “In my years of being involved with humane testing litigation, I know that these things can take some time. Maybe up to a year,” he said. “It also depends how much they want to fight back.”
Neuralink did not immediately respond to our requests for comment.
Beckham’s full letter to the USDA is available below.
2022-02-10 PCRM USDA Complaint Re UC Davis and Neuralink (No Exhibits) by Joey Klender on Scribd
I’d love to hear from you! If you have any comments, concerns, or questions, please email me at joey@teslarati.com. You can also reach me on Twitter @KlenderJoey, or if you have news tips, you can email us at tips@teslarati.com.
Elon Musk
SpaceX is quietly becoming the U.S. Military’s only reliable rocket
Space Force drops ULA for SpaceX on GPS launch after Vulcan rocket anomaly investigation halts flights.
The U.S. Space Force announced today it is switching an upcoming GPS III satellite launch from United Launch Alliance’s Vulcan rocket to a SpaceX Falcon 9, a move that is as much a reflection of Vulcan’s mounting problems as it is a validation of SpaceX’s growing dominance in national security space launch. The GPS III Space Vehicle 09, originally contracted to fly on Vulcan this month, will now target a late April liftoff on Falcon 9, marking the fourth consecutive GPS III satellite the Space Force has moved to SpaceX after contracts were originally awarded to ULA.
The immediate trigger is a solid rocket motor anomaly that occurred on February 12 during Vulcan’s USSF-87 mission. Although the payloads reached orbit and ULA declared the mission successful, the company characterized the malfunction as a “significant performance anomaly” and has since paused all military launches on Vulcan pending a root cause investigation.
“With this change, we are answering the call for rapid delivery of advanced GPS capability while the Vulcan anomaly investigation continues,” said Systems Delta 81 Commander Col. Ryan Hiserote. “We are once again demonstrating our team’s flexibility and are fully committed to leverage all options available for responsive and reliable launch for the Nation.”
The broader reality is that SpaceX’s reliability record and launch cadence have made it the path of least resistance for the Pentagon, and bodes well with Elon Musk’s plans to IPO SpaceX sometime this year. Its Falcon 9 is the most flight-proven rocket in history, and the Space Force’s Rapid Response Trailblazer program was specifically designed to enable exactly this kind of provider swap for GPS missions, and effectively building SpaceX’s flexibility into the national security launch architecture by design.
For ULA, the stakes are existential. The company entered 2026 with aspirations of finally turning a corner after years of Vulcan delays, with interim CEO John Elbon pointing to a backlog of over 80 missions as reason for optimism. Meanwhile, SpaceX’s contracts with the Space Force have given it a formal pathway to take on even more national security launches going forward.
The significance of today’s announcement extends beyond one satellite swap. It reinforces that America’s most critical space infrastructure, including GPS, missile warning, and beyond, is increasingly dependent on a single commercial provider.
News
Tesla Full Self-Driving gets huge breakthrough on European expansion
All documentation for UN R-171 approval and Article 39 exemptions has been submitted, with RDW now conducting its internal review. Approval in the Netherlands is expected on April 10, shifted from the original March 20 target, following 18 months of rigorous collaboration.
Tesla Full Self-Driving has gotten a huge breakthrough as the company is still planning big things for its European expansion, hoping to bring the impressive platform into the continent after years of attempts.
Tesla Europe has announced a major breakthrough: the company has officially completed the final vehicle testing phase for Full Self-Driving (Supervised) in partnership with the Dutch vehicle authority RDW.
All documentation for UN R-171 approval and Article 39 exemptions has been submitted, with RDW now conducting its internal review. Approval in the Netherlands is expected on April 10, shifted from the original March 20 target, following 18 months of rigorous collaboration.
Together with RDW, we have officially completed the final vehicle testing phase for Full Self-Driving (Supervised) and have submitted all documentation required for the UN R-171 approval + Article 39 exemptions. The RDW team is now reviewing the documentation and test results…
— Tesla Europe, Middle East & Africa (@teslaeurope) March 20, 2026
The process has been exhaustive. Tesla said it has logged more than 1.6 million kilometers of FSD (Supervised) testing on European roads, conducted over 13,000 customer ride-alongs, executed 4,500+ track test scenarios, produced thousands of pages of documentation covering 400+ compliance requirements, and completed dozens of independent safety studies.
The company expressed pride in the partnership and anticipation of bringing the feature to “patient EU customers” soon after approval.
Europe’s regulatory landscape has presented steep challenges for Tesla’s advanced driver-assistance systems. The EU enforces some of the world’s strictest safety standards under the United Nations Economic Commission for Europe framework, particularly UN Regulation 171 on Driver Control Assistance Systems.
Unlike the more permissive U.S. environment, European rules historically limited system-initiated maneuvers, required constant driver supervision, and demanded country-by-country or bloc-wide exemptions. Tesla faced repeated delays, with initial February 2026 targets pushed back amid RDW’s insistence that safety, not public or corporate pressure, would govern timelines.
Tesla Europe builds momentum with expanding FSD demos and regional launches
A former Tesla executive warned in 2024 that certain regulatory elements could slip to 2028, highlighting bureaucratic hurdles, extensive audits, and the need for harmonized data privacy and liability frameworks across fragmented member states.
Yet progress is accelerating. Amendments to UN R-171 adopted in 2025 now permit hands-free highway lane changes and other automated features, clearing technical barriers. Once the Netherlands grants national approval, mutual recognition allows other EU countries to adopt it immediately, potentially leading to an EU-wide rollout by summer 2026.
This European breakthrough is part of Tesla’s broader push into foreign markets. Full Self-Driving (Supervised) is already live in the United States and expanding rapidly.
In China, where partial approvals exist, CEO Elon Musk has targeted full rollout around the same February–March 2026 window, despite lingering data-security reviews.
Additional markets, including the UAE, are slated for early 2026 launches. These expansions are critical as Tesla seeks to monetize software amid softening EV demand globally.
For European Tesla owners, the wait appears nearly over. Approval would unlock advanced autonomy features that have long been available elsewhere, marking a pivotal step in Tesla’s global autonomy ambitions and reinforcing its commitment to navigating complex international regulations.
Elon Musk
Tesla’s $2.9 billion bet: Why Elon Musk is turning to China to build America’s solar future
Tesla looks to bring solar manufacturing to the US, with latest $2.9 billion bet to acquire Chinese solar equipment.
Tesla is reportedly in talks to purchase $2.9 billion worth of solar manufacturing equipment from a group of Chinese suppliers, including Suzhou Maxwell Technologies, which is the world’s largest producer of screen-printing equipment used in solar cell production. According to Reuters sources, the equipment is expected to be delivered before autumn and shipped to Texas, where Tesla plans to anchor its next phase of domestic solar production.
The move is a direct extension of a vision Elon Musk has been building for months. At the World Economic Forum in Davos this past January, Musk announced that both Tesla and SpaceX were independently working to establish 100 gigawatts of annual solar manufacturing capacity inside the United States. Days later, on Tesla’s Q4 2025 earnings call, he made the ambition concrete: “We’re going to work toward getting 100 GW a year of solar cell production, integrating across the entire supply chain from raw materials all the way to finished solar panels.”
Job postings on Tesla’s website reflect that same target, with language explicitly calling for 100 GW of “solar manufacturing from raw materials on American soil before the end of 2028.”
The urgency behind the latest solar manufacturing target is rooted in a set of rapidly emerging pressures related to AI and Tesla’s own energy business. U.S. power consumption hit its second consecutive record high in 2025 and is projected to climb further through 2026 and 2027, driven largely by the explosion in AI data centers and the broader electrification of transportation. Tesla’s own energy division, which produces the Megapack utility-scale battery storage system, has been growing rapidly, and solar supply is a critical companion component for the business to scale. Musk has argued that solar is not just a clean energy option but the only one that makes economic sense at the scale AI infrastructure demands.
Tesla lands in Texas for latest Megapack production facility
Ironically, the path to domestic solar independence currently runs through China. Sort of.
Despite Tesla’s stated push to localize its supply chain, mirrored recently by the company’s plan for a $4.3 billion LFP battery manufacturing partnership with LG Energy Solution in Michigan, Tesla still relies on China-based suppliers to keep its cost structure intact.
The $2.9 billion equipment deal underscores a tension Musk himself acknowledged at Davos: “Unfortunately, in the U.S. the tariff barriers for solar are extremely high and that makes the economics of deploying solar artificially high, because China makes almost all the solar.” Building the factory in America requires buying the machinery from the country Tesla is trying to reduce its dependence on.
Tesla named by U.S. Gov. in $4.3B battery deal for American-made cells
The regulatory pathway adds another layer of complexity. Suzhou Maxwell has been seeking export approval from China’s commerce ministry, and it remains unclear how quickly that clearance will come. Still, the market has already reacted, with shares in the Chinese firms reportedly involved in the talks surged more than 7% following the Reuters report that broke the story.
Whether Tesla can hit its 2028 target of 100GW of solar manufacturing remains an open question. Though that scale may seem staggering, especially in such a short timeframe, we know that Musk has a documented history of “always pulling it off” in the face of ambitious deadlines that may slip. But, rest assured – it’ll get done.
